Vimarsana
Biggest News Aggregation in the World

Page 3 - Brian Bourne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Bourne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Bourne Today - Breaking & Trending Today

Long Covid: What is it and why are people not recovering? | Harwich and Manningtree Standard - Vimarsana News

Long Covid: What is it and why are people not recovering? | Harwich and Manningtree Standard

The Government is facing calls to recognise long Covid as an occupation disease - but what is the mystery condition?

UK vaccine chief 'broke Dry January' after British Novavax jab passed - Vimarsana News

UK vaccine chief 'broke Dry January' after British Novavax jab passed

Pills and sprays to replace Covid jabs: Vaccine tsar Kate Bingham says needles will be phased out in battle against mutating virus - and reveals she 'broke Dry January with glass of wine' when she heard UK-made Novavax passed trials with 90% success rate Kate Bingham revealed that she was part of Novavax trial that was found to defeat Covid in 9 out of 10 cases US biotech firm announced its vaccine had successfully completed Phase Three clinical trials in UK Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use The vaccine still requires f...

Another shot in the arm for Britain! 60million MORE jabs set to be made in UK - Vimarsana News

Another shot in the arm for Britain! 60million MORE jabs set to be made in UK

US biotech firm Novavax announced its vaccine had successfully completed Phase Three clinical trials in UK Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use The vaccine still requires final approval from the UK's Medicines and Healthcare products Regulatory Agency The firm Novavax last night said that the trials had shown its coronavirus vaccine was 89.3 per cent effective This trial is the first to be completed since the emergence of the new variant of the Covid-19 disease in Kent